Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients (Q28257370)

Kim Q Do

17

0 references

Ashley I. Bush

Ashley I Bush

8

0 references

Michael Berk

Michael Berk

5

0 references

Thierry Buclin

Thierry Buclin

16

0 references

author name string

Suzie Lavoie

1

0 references

Patricia Deppen

3

0 references

Maria G Knyazeva

4

0 references

Olivier Boulat

6

0 references

Pierre Bovet

7

0 references

Philippe Conus

9

0 references

David Copolov

10

0 references

Eleonora Fornari

11

0 references

Reto Meuli

12

0 references

Alessandra Solida

13

0 references

Pascal Vianin

14

0 references

Michel Cuénod

https://api.crossref.org/works/10.1038/SJ.NPP.1301624

15

0 references

language of work or name

English

0 references

publication date

August 2008

0 references

published in

Neuropsychopharmacology

0 references

volume

33

0 references

issue

9

0 references

page(s)

2187-99

0 references

1 reference

Early selective-attention effect on evoked potential reinterpreted

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1301624

N-acetylcysteine reduced the effect of ethanol on antioxidant system in rat plasma and brain tissue

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Pharmacokinetics of N-acetylcysteine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Early-stage visual processing deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Brain potential evidence for an auditory sensory memory deficit in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Redox modulation of the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Glutamate and schizophrenia: beyond the dopamine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Filling-in in schizophrenia: a high-density electrical mapping and source-analysis investigation of illusory contour processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Electrical neuroimaging based on biophysical constraints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Evoked potential correlates of auditory signal detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Glutathione modulates the N-methyl-D-aspartate receptor-activated calcium influx into cultured rat cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Carbofuran-induced neurochemical and neurobehavioral alterations in rats: attenuation by N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

NMDA receptor channels: subunit-specific potentiation by reducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Reference-free identification of components of checkerboard-evoked multichannel potential fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Mismatch negativity deficits are associated with poor functioning in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Intracellular cysteine and glutathione delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Rapid discrimination of visual and multisensory memories revealed by electrical neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Mapping of scalp potentials by surface spline interpolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Synthesizing schizophrenia: a bottom-up, symptomatic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Mismatch negativity: an index of a preattentive processing deficit in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Learning-induced plasticity in auditory spatial representations revealed by electrical neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Detection of glutathione in the human brain in vivo by means of double quantum coherence filtering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Altered glutathione redox state in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

Mapping event-related brain potential microstates to sentence endings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

Noninvasive localization of electromagnetic epileptic activity. I. Method descriptions and simulations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

Support for an association between mismatch negativity and social functioning in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301624

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301624

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1011937964

0 references

Fatcat ID

release_vt6cpsg6fja3dmsgdu2uyjei4m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vt6cpsg6fja3dmsgdu2uyjei4m

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18004285

1 reference

Consolidated OpenCitations Corpus – April 2017